Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Oral Proteins and Peptides Market Research Report 2025

Global Oral Proteins and Peptides Market Research Report 2025

Industry: Pharma & Healthcare

Published: 2025-01-02

Pages: 77 Pages

Report ld: 3422737

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Oral Proteins and Peptides was valued at US$ 2968 million in the year 2024 and is projected to reach a revised size of US$ 7824 million by 2031, growing at a CAGR of 15.1% during the forecast period.

Polypeptide and protein drugs refer to the biological drugs of polypeptide and protein substances used for prevention,treatment and diagnosis.Polypeptide is a compound formed by linking α-amino acids together with a peptide chain,and it is also an intermediate product of proteolysis.N polypeptide chains are entangled in a certain spatial structure to form a protein.The hydrolysis of macromolecular proteins produces polypeptides.Such drugs are biochemical preparations and have relatively strict requirements on storage and transportation environment.The Oral Proteins and Peptides industry can be broken down into several segments, Linaclotide, Insulin, Plecanatide, Cyclosporine, Octreotide, etc.Across the world, the major players cover Ironwood & Allergan (AbbVie), Novo Nordisk, Synergy Pharmaceuticals (Salix), Novartis, Chiasma (Amryt Pharma), etc.

Ironwood & Allergan is one of the most important global manufacturers of oral proteins and peptides, other key manufacturers include Novo Nordisk. North America is the largest market, occupied for over 60%. In terms of type, insulin is the largest segment, with a share of over 60%. And in terms of application, gastric & digestive disorders and bone diseases segment holds the most share.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Oral Proteins and Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Proteins and Peptides.

The Oral Proteins and Peptides market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Proteins and Peptides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Proteins and Peptides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Report Metric
Details
Report Title
Global Oral Proteins and Peptides Market Research Report 2025
Global Oral Proteins and Peptides Companies Covered
Ironwood & Allergan, Novo Nordisk, Synergy Pharmaceuticals （Salix）, Novartis, Chiasma (Amryt Pharma)
Global Oral Proteins and Peptides Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Proteins and Peptides Market, Segment by Type
Linaclotide

Insulin

Plecanatide

Cyclosporine

Octreotide
Global Oral Proteins and Peptides Market, Segment by Application
Gastric & Digestive Disorders

Bone Diseases

Diabetes

Hormonal Disorders
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Proteins and Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3:  Sales, revenue of Oral Proteins and Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Table of Contents

 1 Oral Proteins and Peptides Market Overview
    1.1 Product Definition
    1.2 Oral Proteins and Peptides by Type
        1.2.1 Global Oral Proteins and Peptides Market Value Comparison by Type (2024 VS 2031)
        1.2.2 Linaclotide
        1.2.3 Insulin
        1.2.4 Plecanatide
        1.2.5 Cyclosporine
        1.2.6 Octreotide
    1.3 Oral Proteins and Peptides by Application
        1.3.1 Global Oral Proteins and Peptides Market Value by Application (2024 VS 2031)
        1.3.2 Gastric & Digestive Disorders
        1.3.3 Bone Diseases
        1.3.4 Diabetes
        1.3.5 Hormonal Disorders
    1.4 Global Oral Proteins and Peptides Market Size Estimates and Forecasts
        1.4.1 Global Oral Proteins and Peptides Revenue 2020-2031
        1.4.2 Global Oral Proteins and Peptides Sales 2020-2031
        1.4.3 Global Oral Proteins and Peptides Market Average Price (2020-2031)
    1.5 Assumptions and Limitations

 2 Oral Proteins and Peptides Market Competition by Manufacturers
    2.1 Global Oral Proteins and Peptides Sales Market Share by Manufacturers (2020-2025)
    2.2 Global Oral Proteins and Peptides Revenue Market Share by Manufacturers (2020-2025)
    2.3 Global Oral Proteins and Peptides Average Price by Manufacturers (2020-2025)
    2.4 Global Key Players of Oral Proteins and Peptides, Industry Ranking, 2022 VS 2023 VS 2024
    2.5 Global Key Manufacturers of Oral Proteins and Peptides, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Oral Proteins and Peptides, Product Type & Application
    2.7 Global Key Manufacturers of Oral Proteins and Peptides, Date of Enter into This Industry
    2.8 Global Oral Proteins and Peptides Market Competitive Situation and Trends
        2.8.1 Global Oral Proteins and Peptides Market Concentration Rate
        2.8.2 The Global 5 and 10 Largest Oral Proteins and Peptides Players Market Share by Revenue
        2.8.3 Global Oral Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Global Oral Proteins and Peptides Market Scenario by Region
    3.1 Global Oral Proteins and Peptides Market Size by Region: 2020 Versus 2024 Versus 2031
    3.2 Global Oral Proteins and Peptides Sales by Region: 2020-2031
        3.2.1 Global Oral Proteins and Peptides Sales by Region: 2020-2025
        3.2.2 Global Oral Proteins and Peptides Sales by Region: 2026-2031
    3.3 Global Oral Proteins and Peptides Revenue by Region: 2020-2031
        3.3.1 Global Oral Proteins and Peptides Revenue by Region: 2020-2025
        3.3.2 Global Oral Proteins and Peptides Revenue by Region: 2026-2031
    3.4 North America Oral Proteins and Peptides Market Facts & Figures by Country
        3.4.1 North America Oral Proteins and Peptides Market Size by Country: 2020 VS 2024 VS 2031
        3.4.2 North America Oral Proteins and Peptides Sales by Country (2020-2031)
        3.4.3 North America Oral Proteins and Peptides Revenue by Country (2020-2031)
        3.4.4 United States
        3.4.5 Canada
    3.5 Europe Oral Proteins and Peptides Market Facts & Figures by Country
        3.5.1 Europe Oral Proteins and Peptides Market Size by Country: 2020 VS 2024 VS 2031
        3.5.2 Europe Oral Proteins and Peptides Sales by Country (2020-2031)
        3.5.3 Europe Oral Proteins and Peptides Revenue by Country (2020-2031)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Oral Proteins and Peptides Market Facts & Figures by Region
        3.6.1 Asia Pacific Oral Proteins and Peptides Market Size by Region: 2020 VS 2024 VS 2031
        3.6.2 Asia Pacific Oral Proteins and Peptides Sales by Region (2020-2031)
        3.6.3 Asia Pacific Oral Proteins and Peptides Revenue by Region (2020-2031)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 China Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
    3.7 Latin America Oral Proteins and Peptides Market Facts & Figures by Country
        3.7.1 Latin America Oral Proteins and Peptides Market Size by Country: 2020 VS 2024 VS 2031
        3.7.2 Latin America Oral Proteins and Peptides Sales by Country (2020-2031)
        3.7.3 Latin America Oral Proteins and Peptides Revenue by Country (2020-2031)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Oral Proteins and Peptides Market Facts & Figures by Country
        3.8.1 Middle East and Africa Oral Proteins and Peptides Market Size by Country: 2020 VS 2024 VS 2031
        3.8.2 Middle East and Africa Oral Proteins and Peptides Sales by Country (2020-2031)
        3.8.3 Middle East and Africa Oral Proteins and Peptides Revenue by Country (2020-2031)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE

 4 Segment by Type
    4.1 Global Oral Proteins and Peptides Sales by Type (2020-2031)
        4.1.1 Global Oral Proteins and Peptides Sales by Type (2020-2025)
        4.1.2 Global Oral Proteins and Peptides Sales by Type (2026-2031)
        4.1.3 Global Oral Proteins and Peptides Sales Market Share by Type (2020-2031)
    4.2 Global Oral Proteins and Peptides Revenue by Type (2020-2031)
        4.2.1 Global Oral Proteins and Peptides Revenue by Type (2020-2025)
        4.2.2 Global Oral Proteins and Peptides Revenue by Type (2026-2031)
        4.2.3 Global Oral Proteins and Peptides Revenue Market Share by Type (2020-2031)
    4.3 Global Oral Proteins and Peptides Price by Type (2020-2031)

 5 Segment by Application
    5.1 Global Oral Proteins and Peptides Sales by Application (2020-2031)
        5.1.1 Global Oral Proteins and Peptides Sales by Application (2020-2025)
        5.1.2 Global Oral Proteins and Peptides Sales by Application (2026-2031)
        5.1.3 Global Oral Proteins and Peptides Sales Market Share by Application (2020-2031)
    5.2 Global Oral Proteins and Peptides Revenue by Application (2020-2031)
        5.2.1 Global Oral Proteins and Peptides Revenue by Application (2020-2025)
        5.2.2 Global Oral Proteins and Peptides Revenue by Application (2026-2031)
        5.2.3 Global Oral Proteins and Peptides Revenue Market Share by Application (2020-2031)
    5.3 Global Oral Proteins and Peptides Price by Application (2020-2031)

 6 Key Companies Profiled
    6.1 Ironwood & Allergan
        6.1.1 Ironwood & Allergan Company Information
        6.1.2 Ironwood & Allergan Description and Business Overview
        6.1.3 Ironwood & Allergan Oral Proteins and Peptides Sales, Revenue and Gross Margin (2020-2025)
        6.1.4 Ironwood & Allergan Oral Proteins and Peptides Product Portfolio
        6.1.5 Ironwood & Allergan Recent Developments/Updates
    6.2 Novo Nordisk
        6.2.1 Novo Nordisk Company Information
        6.2.2 Novo Nordisk Description and Business Overview
        6.2.3 Novo Nordisk Oral Proteins and Peptides Sales, Revenue and Gross Margin (2020-2025)
        6.2.4 Novo Nordisk Oral Proteins and Peptides Product Portfolio
        6.2.5 Novo Nordisk Recent Developments/Updates
    6.3 Synergy Pharmaceuticals （Salix）
        6.3.1 Synergy Pharmaceuticals （Salix） Company Information
        6.3.2 Synergy Pharmaceuticals （Salix） Description and Business Overview
        6.3.3 Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Sales, Revenue and Gross Margin (2020-2025)
        6.3.4 Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Product Portfolio
        6.3.5 Synergy Pharmaceuticals （Salix） Recent Developments/Updates
    6.4 Novartis
        6.4.1 Novartis Company Information
        6.4.2 Novartis Description and Business Overview
        6.4.3 Novartis Oral Proteins and Peptides Sales, Revenue and Gross Margin (2020-2025)
        6.4.4 Novartis Oral Proteins and Peptides Product Portfolio
        6.4.5 Novartis Recent Developments/Updates
    6.5 Chiasma (Amryt Pharma)
        6.5.1 Chiasma (Amryt Pharma) Company Information
        6.5.2 Chiasma (Amryt Pharma) Description and Business Overview
        6.5.3 Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales, Revenue and Gross Margin (2020-2025)
        6.5.4 Chiasma (Amryt Pharma) Oral Proteins and Peptides Product Portfolio
        6.5.5 Chiasma (Amryt Pharma) Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Oral Proteins and Peptides Industry Chain Analysis
    7.2 Oral Proteins and Peptides Raw Material Supply Analysis
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Oral Proteins and Peptides Production Mode & Process Analysis
    7.4 Oral Proteins and Peptides Sales and Marketing
        7.4.1 Oral Proteins and Peptides Sales Channels
        7.4.2 Oral Proteins and Peptides Distributors
    7.5 Oral Proteins and Peptides Customer Analysis

 8 Oral Proteins and Peptides Market Dynamics
    8.1 Oral Proteins and Peptides Industry Trends
    8.2 Oral Proteins and Peptides Market Drivers
    8.3 Oral Proteins and Peptides Market Challenges
    8.4 Oral Proteins and Peptides Market Restraints

 9 Research Findings and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Oral Proteins and Peptides Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Oral Proteins and Peptides Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Oral Proteins and Peptides Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Oral Proteins and Peptides Sales (Kg) of Key Manufacturers (2020-2025)
 Table 5. Global Oral Proteins and Peptides Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Oral Proteins and Peptides Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Oral Proteins and Peptides Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Oral Proteins and Peptides Average Price (US$/Mg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Oral Proteins and Peptides, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Oral Proteins and Peptides, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Oral Proteins and Peptides, Product Type & Application
 Table 12. Global Key Manufacturers of Oral Proteins and Peptides, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Oral Proteins and Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Proteins and Peptides as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Oral Proteins and Peptides Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Oral Proteins and Peptides Sales by Region (2020-2025) & (Kg)
 Table 18. Global Oral Proteins and Peptides Sales Market Share by Region (2020-2025)
 Table 19. Global Oral Proteins and Peptides Sales by Region (2026-2031) & (Kg)
 Table 20. Global Oral Proteins and Peptides Sales Market Share by Region (2026-2031)
 Table 21. Global Oral Proteins and Peptides Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Oral Proteins and Peptides Revenue Market Share by Region (2020-2025)
 Table 23. Global Oral Proteins and Peptides Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Oral Proteins and Peptides Revenue Market Share by Region (2026-2031)
 Table 25. North America Oral Proteins and Peptides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Oral Proteins and Peptides Sales by Country (2020-2025) & (Kg)
 Table 27. North America Oral Proteins and Peptides Sales by Country (2026-2031) & (Kg)
 Table 28. North America Oral Proteins and Peptides Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Oral Proteins and Peptides Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Oral Proteins and Peptides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Oral Proteins and Peptides Sales by Country (2020-2025) & (Kg)
 Table 32. Europe Oral Proteins and Peptides Sales by Country (2026-2031) & (Kg)
 Table 33. Europe Oral Proteins and Peptides Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Oral Proteins and Peptides Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Oral Proteins and Peptides Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Oral Proteins and Peptides Sales by Region (2020-2025) & (Kg)
 Table 37. Asia Pacific Oral Proteins and Peptides Sales by Region (2026-2031) & (Kg)
 Table 38. Asia Pacific Oral Proteins and Peptides Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Oral Proteins and Peptides Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Oral Proteins and Peptides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Oral Proteins and Peptides Sales by Country (2020-2025) & (Kg)
 Table 42. Latin America Oral Proteins and Peptides Sales by Country (2026-2031) & (Kg)
 Table 43. Latin America Oral Proteins and Peptides Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Oral Proteins and Peptides Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Oral Proteins and Peptides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Oral Proteins and Peptides Sales by Country (2020-2025) & (Kg)
 Table 47. Middle East and Africa Oral Proteins and Peptides Sales by Country (2026-2031) & (Kg)
 Table 48. Middle East and Africa Oral Proteins and Peptides Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Oral Proteins and Peptides Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Oral Proteins and Peptides Sales (Kg) by Type (2020-2025)
 Table 51. Global Oral Proteins and Peptides Sales (Kg) by Type (2026-2031)
 Table 52. Global Oral Proteins and Peptides Sales Market Share by Type (2020-2025)
 Table 53. Global Oral Proteins and Peptides Sales Market Share by Type (2026-2031)
 Table 54. Global Oral Proteins and Peptides Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Oral Proteins and Peptides Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Oral Proteins and Peptides Revenue Market Share by Type (2020-2025)
 Table 57. Global Oral Proteins and Peptides Revenue Market Share by Type (2026-2031)
 Table 58. Global Oral Proteins and Peptides Price (US$/Mg) by Type (2020-2025)
 Table 59. Global Oral Proteins and Peptides Price (US$/Mg) by Type (2026-2031)
 Table 60. Global Oral Proteins and Peptides Sales (Kg) by Application (2020-2025)
 Table 61. Global Oral Proteins and Peptides Sales (Kg) by Application (2026-2031)
 Table 62. Global Oral Proteins and Peptides Sales Market Share by Application (2020-2025)
 Table 63. Global Oral Proteins and Peptides Sales Market Share by Application (2026-2031)
 Table 64. Global Oral Proteins and Peptides Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Oral Proteins and Peptides Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Oral Proteins and Peptides Revenue Market Share by Application (2020-2025)
 Table 67. Global Oral Proteins and Peptides Revenue Market Share by Application (2026-2031)
 Table 68. Global Oral Proteins and Peptides Price (US$/Mg) by Application (2020-2025)
 Table 69. Global Oral Proteins and Peptides Price (US$/Mg) by Application (2026-2031)
 Table 70. Ironwood & Allergan Company Information
 Table 71. Ironwood & Allergan Description and Business Overview
 Table 72. Ironwood & Allergan Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 73. Ironwood & Allergan Oral Proteins and Peptides Product
 Table 74. Ironwood & Allergan Recent Developments/Updates
 Table 75. Novo Nordisk Company Information
 Table 76. Novo Nordisk Description and Business Overview
 Table 77. Novo Nordisk Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 78. Novo Nordisk Oral Proteins and Peptides Product
 Table 79. Novo Nordisk Recent Developments/Updates
 Table 80. Synergy Pharmaceuticals （Salix） Company Information
 Table 81. Synergy Pharmaceuticals （Salix） Description and Business Overview
 Table 82. Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 83. Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Product
 Table 84. Synergy Pharmaceuticals （Salix） Recent Developments/Updates
 Table 85. Novartis Company Information
 Table 86. Novartis Description and Business Overview
 Table 87. Novartis Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 88. Novartis Oral Proteins and Peptides Product
 Table 89. Novartis Recent Developments/Updates
 Table 90. Chiasma (Amryt Pharma) Company Information
 Table 91. Chiasma (Amryt Pharma) Description and Business Overview
 Table 92. Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 93. Chiasma (Amryt Pharma) Oral Proteins and Peptides Product
 Table 94. Chiasma (Amryt Pharma) Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Oral Proteins and Peptides Distributors List
 Table 98. Oral Proteins and Peptides Customers List
 Table 99. Oral Proteins and Peptides Market Trends
 Table 100. Oral Proteins and Peptides Market Drivers
 Table 101. Oral Proteins and Peptides Market Challenges
 Table 102. Oral Proteins and Peptides Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Oral Proteins and Peptides
 Figure 2. Global Oral Proteins and Peptides Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Oral Proteins and Peptides Market Share by Type: 2024 & 2031
 Figure 4. Linaclotide Product Picture
 Figure 5. Insulin Product Picture
 Figure 6. Plecanatide Product Picture
 Figure 7. Cyclosporine Product Picture
 Figure 8. Octreotide Product Picture
 Figure 9. Global Oral Proteins and Peptides Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Oral Proteins and Peptides Market Share by Application: 2024 & 2031
 Figure 11. Gastric & Digestive Disorders
 Figure 12. Bone Diseases
 Figure 13. Diabetes
 Figure 14. Hormonal Disorders
 Figure 15. Global Oral Proteins and Peptides Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Oral Proteins and Peptides Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Oral Proteins and Peptides Sales (2020-2031) & (Kg)
 Figure 18. Global Oral Proteins and Peptides Average Price (US$/Mg) & (2020-2031)
 Figure 19. Oral Proteins and Peptides Report Years Considered
 Figure 20. Oral Proteins and Peptides Sales Share by Manufacturers in 2024
 Figure 21. Global Oral Proteins and Peptides Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Oral Proteins and Peptides Players: Market Share by Revenue in Oral Proteins and Peptides in 2024
 Figure 23. Oral Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Oral Proteins and Peptides Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Oral Proteins and Peptides Sales Market Share by Country (2020-2031)
 Figure 26. North America Oral Proteins and Peptides Revenue Market Share by Country (2020-2031)
 Figure 27. United States Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Oral Proteins and Peptides Sales Market Share by Country (2020-2031)
 Figure 30. Europe Oral Proteins and Peptides Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Oral Proteins and Peptides Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Oral Proteins and Peptides Revenue Market Share by Region (2020-2031)
 Figure 38. China Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Oral Proteins and Peptides Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Oral Proteins and Peptides Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Oral Proteins and Peptides Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Oral Proteins and Peptides Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Oral Proteins and Peptides by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Oral Proteins and Peptides by Type (2020-2031)
 Figure 59. Global Oral Proteins and Peptides Price (US$/Mg) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Oral Proteins and Peptides by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Oral Proteins and Peptides by Application (2020-2031)
 Figure 62. Global Oral Proteins and Peptides Price (US$/Mg) by Application (2020-2031)
 Figure 63. Oral Proteins and Peptides Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed

Description

The global market for Oral Proteins and Peptides was valued at US$ 2968 million in the year 2024 and is projected to reach a revised size of US$ 7824 million by 2031, growing at a CAGR of 15.1% during the forecast period.

Polypeptide and protein drugs refer to the biological drugs of polypeptide and protein substances used for prevention,treatment and diagnosis.Polypeptide is a compound formed by linking α-amino acids together with a peptide chain,and it is also an intermediate product of proteolysis.N polypeptide chains are entangled in a certain spatial structure to form a protein.The hydrolysis of macromolecular proteins produces polypeptides.Such drugs are biochemical preparations and have relatively strict requirements on storage and transportation environment.The Oral Proteins and Peptides industry can be broken down into several segments, Linaclotide, Insulin, Plecanatide, Cyclosporine, Octreotide, etc.Across the world, the major players cover Ironwood & Allergan (AbbVie), Novo Nordisk, Synergy Pharmaceuticals (Salix), Novartis, Chiasma (Amryt Pharma), etc.

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Proteins and Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3:  Sales, revenue of Oral Proteins and Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Industry: Pharma & Healthcare

Published: 2025-01-02

Pages: 77 Pages

Report ld: 3422737

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 2900.00

Multi Users License

USD 4350.00

Corporate Users License